Quick Answer
BIOGEN INC. reported Net Income of $1.29 billion for fiscal year 2025.
BIOGEN INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $1.29B | -20.8% |
| 2024 | $1.63B | +40.6% |
| 2023 | $1.16B | -61.9% |
| 2022 | $3.05B | +95.8% |
| 2021 | $1.56B | -61.1% |
| 2020 | $4.00B | -32.1% |
| 2019 | $5.89B | +32.9% |
| 2018 | $4.43B | +74.5% |
| 2017 | $2.54B | -31.4% |
| 2016 | $3.70B | +4.4% |
| 2015 | $3.55B | +20.9% |
| 2014 | $2.93B | +57.6% |
| 2013 | $1.86B | +34.9% |
| 2012 | $1.38B | +11.8% |
| 2011 | $1.23B | +22.8% |
| 2010 | $1.01B | +3.6% |
| 2009 | $970.13M | +23.9% |
| 2008 | $783.17M | +22.7% |
| 2007 | $638.17M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $466.50M | +20.1% | -26.5% |
| June 30, 2025 | $634.80M | +8.8% | +164.0% |
| March 31, 2025 | $240.50M | -38.9% | -38.1% |
| September 30, 2024 | $388.50M | +670.5% | -33.4% |
| June 30, 2024 | $583.60M | -1.4% | +48.3% |
| March 31, 2024 | $393.40M | +1.4% | +677.7% |
| September 30, 2023 | -$68.10M | -106.0% | -111.5% |
| June 30, 2023 | $591.60M | -44.1% | +52.5% |
- BIOGEN INC. showed a decrease of -20.8% in Net Income compared to the prior fiscal year.
- Over the 2007–2025 period, BIOGEN INC.’s net income has grown by 102.6% (from $638.17 million to $1.29 billion).
- The most recent figure is from BIOGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: